Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
05/21/1991 | US5017564 Solid pharmaceutical preparation and method of producing same |
05/21/1991 | US5017379 Time-release, immunology |
05/21/1991 | US5017366 Sunscreen, erythromycin |
05/21/1991 | US5017229 Water insoluble derivatives of hyaluronic acid |
05/21/1991 | CA2030029A1 Emulsified composition |
05/17/1991 | CA2030006A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin |
05/17/1991 | CA2029929A1 Compounds to be used as carriers for active chemical, physical or biological products or other substances |
05/16/1991 | WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
05/16/1991 | WO1991006309A1 Method of in vivo delivery of functioning foreign genes |
05/16/1991 | WO1991006290A1 Bioadhesive composition and patch |
05/16/1991 | WO1991006289A1 Mucoadhesive carrier for delivery of therapeutical agent |
05/16/1991 | WO1991006283A1 Tissue moisturizing composition and method |
05/16/1991 | DE4035442A1 Medicament contg. r- or s- alpha-lipoic acid |
05/16/1991 | DE3938030A1 Verfahren zur herstellung waessriger mischmicelloesungen A process for the preparation of aqueous mixed micelle |
05/16/1991 | CA2029997A1 Polymyxin conjugates |
05/16/1991 | CA2029940A1 Use of new injectable biodegradable microspheres, process for preparation thereof and injectable suspension comprising them |
05/15/1991 | EP0427247A2 Pharmaceutical composition with R-alpha-lipoic acid or S-alpha-lipoic acid as the active ingredient |
05/15/1991 | EP0427185A2 Copolymers from trimethylenecarbonate and optically inactive lactides |
05/15/1991 | EP0427157A2 Endermic medicament with a gel base |
05/15/1991 | EP0427078A1 Folinic acid-cyclodextrin inclusion compound |
05/15/1991 | EP0426974A2 Composition containing acetaminophen |
05/15/1991 | EP0261234B1 Dual phase solvent carrier system |
05/15/1991 | EP0259468B1 Cyclodextrinclathrates of carbacycline derivatives and their use as medicinal drugs |
05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
05/15/1991 | CN1051367A Yttrium and rare earth compounds catalyzed lactone polymerization |
05/14/1991 | WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
05/14/1991 | WO1991007182A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
05/14/1991 | WO1991007171A1 Lipospheres for controlled delivery of substances |
05/14/1991 | US5015632 Germicides for skins |
05/14/1991 | US5015627 Stabilized somatotropin for parenteral administration |
05/14/1991 | US5015481 Stabilized pharmaceutical admixture composition |
05/14/1991 | US5015479 Sustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridine |
05/14/1991 | US5015474 Yerba santa extract for topical application or vaginal douche |
05/14/1991 | CA2068325A1 Rrna specific oligonucleotides |
05/14/1991 | CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
05/11/1991 | CA2029667A1 Process |
05/09/1991 | CA2028354A1 Substantially anhydrous complexes of pvp and h o |
05/08/1991 | WO1991006288A1 A nicotine containing stimulant unit |
05/08/1991 | EP0426463A2 Method of encapsulating biologically active substances, a capsule produced by the method, its use, and a fodder containing such capsules |
05/08/1991 | EP0426434A1 Sugar beet pectins and their use in comestibles |
05/08/1991 | EP0426055A2 Copolymers from lactic acid and tartaric acid, their preparation and their use |
05/08/1991 | EP0426029A1 Injectable formulation for lipophilic drugs |
05/08/1991 | EP0425968A2 Novel multiple layer transdermal drug administration system |
05/08/1991 | EP0425639A1 Plant protecting preparations, veterinary and additive preparations. |
05/08/1991 | EP0425505A1 Transdermal antisecretory agents for gastrointestinal disease. |
05/08/1991 | EP0374252A4 Injection-type hemostatic composition |
05/08/1991 | EP0362321A4 Ophthalmic suspensions |
05/07/1991 | WO1991006287A1 Protein microspheres and methods of using them |
05/07/1991 | WO1991006286A1 Method for producing protein microspheres |
05/07/1991 | US5013868 Process for treating amphoteric amino acids |
05/07/1991 | US5013855 Reacting a 3-halo-1,2-propanediol sulfate with a phenol in the presence of base |
05/07/1991 | US5013747 Water-soluble antiseptic or antifungal composition |
05/07/1991 | US5013728 Composition for treating osteoporosis and hormonal imbalance |
05/07/1991 | US5013726 External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion |
05/07/1991 | US5013716 Flavor with chlorodeoxysugars, medicines |
05/07/1991 | US5013715 Polymethylphenylsiloxane And A Saccharose Fatty Acid Ester; Cosmetic and Medicinal Uses |
05/07/1991 | US5013713 Prolonged release of biologically active somatotropin |
05/07/1991 | US5013556 Lipids derivatized with polyoxyethylene glycol, drug delivery, antitumor agents |
05/07/1991 | US5013554 Administering antitussive dextrorphan citrate |
05/07/1991 | US5013547 Anticancer drug - antibody conjugates and method for preparing same |
05/07/1991 | US5013545 Ethanol, antihistamine |
05/07/1991 | US5013541 Poly(alpha-hydroxy acrylic acid) and derivatives as antitartar actives in oral compositions |
05/07/1991 | CA2071867A1 Method for producing protein microspheres |
05/07/1991 | CA1283998C Coatable ion exchange resins |
05/05/1991 | WO1991006282A1 Small particle drug compositions |
05/04/1991 | CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
05/03/1991 | WO1991006322A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
05/03/1991 | CA2045504A1 Magnetically controlled carrier with physiologically active agent and process for preparing thereof |
05/02/1991 | WO1991005795A1 Stem cell factor |
05/02/1991 | WO1991005605A1 Cyclodextrin labels for immunoassay and biochemical analysis |
05/02/1991 | WO1991005544A1 Drug delivery system, method for preparing the same, and use thereof |
05/02/1991 | WO1991005529A1 Drug delivery systems and matrix therefor |
05/02/1991 | EP0425443A1 Injectable antiparasitic agent |
05/02/1991 | EP0425373A1 Pharmaceutical and cosmetic composition containing cross-linked poly-beta-alamine spheres impregnated by lipophilic substances |
05/02/1991 | EP0425298A2 Sustained-release preparation of basic medical agent hydrochloride |
05/02/1991 | EP0425268A2 Phosphazene polymer carrier for biologically active substance |
05/02/1991 | EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use |
05/02/1991 | EP0425154A1 Sustained release elements |
05/02/1991 | EP0425023A2 Cellulosic coating |
05/02/1991 | EP0424679A2 Protection of a food product, a cosmetic product or a pharmaceutical product against oxydation |
05/02/1991 | EP0424386A1 Device for site directed neovascularization and method for same |
05/02/1991 | DE3938227C1 Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol |
05/02/1991 | CA2029022A1 Sugar beet pectins and their use in comestibles |
05/01/1991 | WO1991006310A1 Liposomal compositions |
05/01/1991 | CN1050987A Stable immunogen composition for oral administration |
05/01/1991 | CA2066698A1 Liposomal compositions |
05/01/1991 | CA2028604A1 Injectable formulation for lipophilic drugs |
04/30/1991 | US5011913 Complexing with technetium; scanning agents, medical diagnosis |
04/30/1991 | US5011855 Oil extracted from pips of Ribes genus fruits |
04/30/1991 | US5011852 Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
04/30/1991 | US5011694 Exposing matrix of compressed mixture of powdered drug and polymer to vapor of lower alcohol |
04/30/1991 | US5011693 Haemostatic agents |
04/30/1991 | US5011686 Injectable reagent with affinity for fibrin |
04/30/1991 | US5011678 Suspension of biocompatible polypeptide drug, steroid and fluorocarbon propellant; for mucosal area; antidiabetic, osteoporosis, Paget*s disease; sodium tauro-24,25-dihydro-fusidate |
04/30/1991 | US5011677 For radiation therapy |
04/30/1991 | US5010685 Encapsulated in mixture of ethylene-vinyl acetate copolymer and wax matrices |
04/30/1991 | CA1283750C Platinum co-ordination compounds |
04/30/1991 | CA1283661C Imidazolides, process for their preparation and application as intermediates for the synthesis of cytotoxic conjugates |
04/30/1991 | CA1283655C Acid decrystallization of aminopolysaccharides and derivatives thereof |
04/30/1991 | CA1283607C Stable injectable pharmaceutical formulation for 1,4- dihydroxy-5-8-bis¬2-(2-hydroxyethylamino)-ethylamino| anthraquinone, dihydrochloride |